• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER®AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER®AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number PLA320400
Medical Device Problem Code Fluid/Blood Leak (1250)
Health Effect - Clinical Code Aneurysm (1708)
Date of Event 05/20/2022
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
As gore was unable to determine which device was involved in the event if any; additional device(s) implanted include: rlt311413/18392906 (udi: (b)(4)), plc271000/ 18220741(udi: (b)(4)), plc271000/ 18220740 (udi: (b)(4)).The instructions for use (ifu) for the gore® excluder® aaa endoprosthesis states, adverse events that may occur and / or require intervention include but are not limited to: endoleak.
 
Event or Problem Description
The following details were reported to gore: physician reported patient has proximal type i endoleak and a distal type i endoleak on the right side, possible reintervention to occur over the weekend.That's all the information i have at this time, just need to know what devices are implanted in the patient.
 
Additional Manufacturer Narrative
B5: additional information provided.
 
Event or Problem Description
On (b)(6), 2018, this patient underwent endovascular treatment for an abdomincal aortic aneurysm and was implanted with gore® excluder® aaa endoprostheses featuring c3® delivery system.The patient tolerated the procedure.On (b)(6), 2022, the physician reported the patient has a proximal type i endoleak and a distal type i endoleak on the right side, possible reintervention to occur over the weekend.On (b)(6), 2022, the physician reported that the patient is refusing additional treatment, there is no reintervention scheduled at this time.
 
Additional Manufacturer Narrative
B1: additional information.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® EXCLUDER®AAA ENDOPROSTHESIS
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL SILICON VALLEY B/P
2890 de la cruz blvd.
santa clara CA 95050
Manufacturer Contact
laura crawford
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key14567783
Report Number3013164176-2022-01389
Device Sequence Number5096185
Product Code MIH
UDI-Device Identifier00733132618804
UDI-Public00733132618804
Combination Product (Y/N)N
Initial Reporter StateNJ
Initial Reporter CountryUS
PMA/510(K) Number
P020004
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2018
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 10/10/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date04/16/2021
Device Model NumberPLA320400
Device Catalogue NumberPLA320400
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/20/2022
Supplement Date Received by Manufacturer05/20/2022
05/20/2022
Initial Report FDA Received Date06/01/2022
Supplement Report FDA Received Date06/01/2022
10/10/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured04/17/2018
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other; Hospitalization;
Patient Age77 YR
Patient SexFemale
-
-